Cargando…
Identification of a novel peptide targeting TIGIT to evaluate immunomodulation of (125)I seed brachytherapy in HCC by near-infrared fluorescence
INTRODUCTION: Hepatocellular carcinoma (HCC) has very poor prognosis due to its immunosuppressive properties. An effective measure to regulate tumor immunity is brachytherapy, which uses (125)I seeds planted into tumor. T cell immune receptors with immunoglobulin and ITIM domains (TIGIT) is highly e...
Autores principales: | Zeng, Peng, Shen, Duo, Shu, Wenbin, Min, Shudan, Shu, Min, Yao, Xijuan, Wang, Yong, Chen, Rong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10141647/ https://www.ncbi.nlm.nih.gov/pubmed/37124530 http://dx.doi.org/10.3389/fonc.2023.1143266 |
Ejemplares similares
-
Brachytherapy with Iodine-125 seeds for treatment of portal vein-branch tumor thrombus in patients with hepatocellular carcinoma
por: Hong, Duo, et al.
Publicado: (2021) -
Experimental study of pelvic perioperative brachytherapy with iodine 125 seeds (I-125) in an animal model
por: Brun, Thomas, et al.
Publicado: (2018) -
Bioevaluation of (125)I Ocu-Prosta seeds for application in prostate cancer brachytherapy
por: Mukherjee, Archana, et al.
Publicado: (2014) -
Treasure of the Past IX: Exposure Standardization of Iodine-125 Seeds Used for Brachytherapy
por: Loftus, T. P.
Publicado: (2001) -
Late seed migration after prostate brachytherapy with Iod-125 permanent implants
por: Maletzki, Philipp, et al.
Publicado: (2018)